Regulatory T cells and transplantation tolerance

Area of Science:

• Immunology
• Transplantation Biology
• Immunotherapy

Background:

• Organ transplantation necessitates lifelong immunosuppression to prevent graft rejection.
• Preclinical models show short-term blockade of T-cell costimulation can induce long-term tolerance.
• This tolerance is dependent on the induction of Foxp3⁺ regulatory T cells (Tregs).

Purpose of the Study:

• To explore novel therapeutic targets for inducing and stabilizing Foxp3⁺ Tregs in vivo.
• To investigate the potential of harnessing endogenous Tregs for clinical transplantation tolerance.
• To advance the translation of Treg-based therapies from animal models to human patients.

Main Methods:

• Utilized preclinical mouse models of organ transplantation.
• Investigated molecular and epigenetic mechanisms controlling Foxp3 expression and Treg differentiation.
• Identified and evaluated pharmacological compounds targeting key pathways for Treg induction.

Main Results:

• Demonstrated that T-cell coreceptor and costimulation blockade can induce robust, long-term tolerance in fully mismatched grafts.
• Confirmed the essential role of Foxp3⁺ Tregs in establishing and maintaining the tolerant state.
• Identified specific molecular targets and available compounds for in vivo Treg induction.

Conclusions:

• Therapeutically induced tolerance via Foxp3⁺ Tregs offers a potential alternative to chronic immunosuppression.
• Targeting intracellular mechanisms of Foxp3⁺ Treg differentiation holds significant promise for clinical translation.
• Development of pharmacological agents to harness endogenous Tregs could revolutionize organ transplantation.